Julia Lopez MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
8 published records · newest first.
Written questions
Life SciencesDepartment of Health and Social CareTabled 4 Feb 2026AnsweredUIN 110858More
Question: To ask the Secretary of State for Health and Social Care, with reference to the correspondence from the Minister for Science, Innovation, Research and Nuclear to the Chair of the Science, Innovation and Technology Committee, dated 30 January 2026, if he w
Answer: There are no current plans to publish the joint analysis undertaken by the Department, NHS England, and the National Institute for Health and Care Excellence (NICE) on the cost of the United Kingdom and United States’ pharmaceutical trade deal.Tens of tho...
Answered 9 Feb 2026
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 10 Dec 2025AnsweredUIN 98909More
Question: To ask the Secretary of State for Health and Social Care, whether the UK is (a) excluded from, (b) partially exempted from and (c) otherwise subject to special treatment under the United States’ Most Favoured Nation drug pricing policy.
Answer: Thanks to strong United Kingdom support for innovation, the UK has secured mitigations under the United States’ ‘Most Favoured Nation’ drug pricing initiative so that we will continue to ensure access to the latest treatments. This will encourage pharmace...
Answered 17 Dec 2025
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 5 Dec 2025AnsweredUIN 97665More
Question: To ask the Secretary of State for Health and Social Care, whether the capped VPAG rate referred to in the UK-US Economic Prosperity Deal will only apply to pharmaceutical products of US origin.
Answer: The capped rate applies to all newer medicines, not just pharmaceutical products originating from the United States.
Answered 17 Dec 2025
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 4 Dec 2025AnsweredUIN 97253More
Question: To ask the Secretary of State for Health and Social Care, from which Department’s budget the additional NHS medicines spend following the UK-US Economic Prosperity Deal will be funded.
Answer: Every patient deserves access to the best possible treatment. This deal is a vital investment that builds on the strength of our National Health Service and world leading life sciences sector.Costs will start smaller but will increase over time as the Nat...
Answered 17 Dec 2025
Original Parliament recordNHS: DrugsDepartment of Health and Social CareTabled 4 Dec 2025AnsweredUIN 97252More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 25% net increase in prices for new medicines and the 15% VPAG repayment cap on annual NHS medicines spend.
Answer: Every patient deserves access to the best possible treatment. This deal is a vital investment that builds on the strength of our National Health Service and world leading life sciences sector.Costs will start smaller but will increase over time as the Nat...
Answered 17 Dec 2025
Original Parliament recordVisual Impairment: RehabilitationDepartment of Health and Social CareTabled 25 Nov 2025AnsweredUIN 94360More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to secure a sustainable future for the vision rehabilitation workforce.
Answer: We are progressing towards a National Care Service, and this includes expanding career opportunities through the Care Workforce Pathway, and investing £12 million in learning, development, and new qualifications. The Level 2 Adult Social Care Certificate ...
Answered 2 Dec 2025
Original Parliament recordVisual Impairment: RehabilitationDepartment of Health and Social CareTabled 25 Nov 2025AnsweredUIN 94359More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of (a) the effect of no national oversight relating to the quality of vision rehabilitation services for patients in England and (b) the experiences of those
Answer: Under the Care Act 2014, local authorities have the duty to shape their care market and to commission a range of high-quality, sustainable, and person-centred care and support services to meet the diverse needs of all local people. This includes encouragi...
Answered 2 Dec 2025
Original Parliament recordVisual Impairment: RehabilitationDepartment of Health and Social CareTabled 25 Nov 2025AnsweredUIN 94358More
Question: To ask the Secretary of State for Health and Social Care, if he will make an assessment of recent trends in the number of patients receiving timely access to vision rehabilitation services in line with industry best practice.
Answer: The Care Quality Commission (CQC) is now assessing how local authorities are meeting the full range of their duties under Part 1 of the Care Act 2014. These assessments identify local authorities’ strengths and areas for development, facilitating the shar...
Answered 2 Dec 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →